Streetbeat News

Regulatory

NVCR

Novocure announced that the FDA has approved its product, Optune Lua, for the treatment of metastatic non-small cell lung cancer. This approval could potentially enhance Novocure's market position and revenue prospects.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:44 pm

NVCR

NovoCure's shares rose following FDA approval of Optune Lua for treating metastatic non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:39 pm

URGN

UroGen Pharma's shares rose following the FDA's acceptance of its new drug application for UGN-102.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:35 pm

CTCX

Carmell Corp has filed a Form RW with the SEC, indicating that it will not pursue a previously planned securities offering. The company confirmed that no securities have been issued or sold, and the registration statement has not been declared effective.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:34 pm

BDRX

Biodexa Pharmaceuticals shares rose after successfully appealing Nasdaq's delisting decision, gaining more time to comply with listing rules.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:33 pm

URGN

UroGen Pharma Ltd. announced that the FDA has accepted its New Drug Application for UGN-102, a potential treatment for low-grade intermediate-risk non-muscle invasive bladder cancer. The PDUFA goal date is set for June 13, 2025.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:32 pm

BDRX

Biodexa Pharmaceuticals has been granted an extension by the Nasdaq Hearings Panel to meet the $1 minimum bid price requirement. This extension provides the company additional time to comply with Nasdaq's listing rules.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:31 pm

BA

SPY

A U.S. judge has ordered Boeing and the government to provide additional briefing by October 25 regarding a plea deal. This development is part of ongoing legal proceedings involving Boeing.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:29 pm

ISRA

ITA

The U.S. has warned Israel to improve humanitarian conditions in Gaza within 30 days or face potential restrictions on military aid. This has led to a slight decline in U.S. defense stocks, while Israel ETFs have risen.

Portfolio Pulse from Piero Cingari

October 15, 2024 | 8:19 pm

SVCO

Silvaco has reported a decline in orders from Asia during the third quarter, primarily due to economic challenges and ongoing US-China trade tensions.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:16 pm